Thomas A. D’Amico

Active 1999–2025

115
Papers
26,431
Citations
81
h-index
112
i10-index

Citations

Citations per year for Thomas A. D’Amico1990: 1 citations1993: 1 citations1999: 2 citations2000: 5 citations2001: 9 citations2002: 17 citations2003: 25 citations2004: 13 citations2005: 24 citations2006: 21 citations2007: 43 citations2008: 44 citations2009: 56 citations2010: 74 citations2011: 93 citations2012: 104 citations2013: 134 citations2014: 145 citations2015: 97 citations2016: 129 citations2017: 122 citations2018: 136 citations2019: 826 citations2020: 837 citations2021: 803 citations2022: 735 citations2023: 528 citations2024: 1,071 citations2025: 338 citations2026: 10 citations1991–1992: no citations, so these years are not shown1994–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,246 citing papers, 26.9% of this breakdownUnited States: 1,858 citing papers, 22.2% of this breakdownJapan: 406 citing papers, 4.9% of this breakdownUnited Kingdom: 348 citing papers, 4.2% of this breakdownItaly: 341 citing papers, 4.1% of this breakdownGermany: 262 citing papers, 3.1% of this breakdownSouth Korea: 246 citing papers, 2.9% of this breakdownCanada: 243 citing papers, 2.9% of this breakdownFrance: 224 citing papers, 2.7% of this breakdownNetherlands: 197 citing papers, 2.4% of this breakdownSpain: 193 citing papers, 2.3% of this breakdownAustralia: 155 citing papers, 1.9% of this breakdown
0%26.9%Other 19.5%

Fields

  • Medicine81.8%
  • Biochemistry, Genetics and Molecular Biology13.6%
  • Immunology and Microbiology1.3%
  • Engineering0.7%
  • Computer Science0.5%
  • Neuroscience0.5%
  • Other1.6%

Topics

  • Lung Cancer Diagnosis and Treatment10.6%
  • Lung Cancer Treatments and Mutations8.2%
  • Cancer Immunotherapy and Biomarkers5.2%
  • Gastric Cancer Management and Outcomes5%
  • Lung Cancer Research Studies4.8%
  • Esophageal Cancer Research and Treatment4.4%
  • Other61.8%

Coauthors

All papers

Open in search
  1. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott I. Reznik, Robert E. Roses, Vivian E. Strong, Stacey Su, Hanlin L. Wang, Georgia L. Wiesner, Christopher G. Willett, Danny Yakoub, Harry H. Yoon, Nicole R. McMillian, Lenora A. Pluchino - Journal of the National Comprehensive Cancer Network 2022 cited by 1,703

  2. Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2022 cited by 1,419

  3. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George A. Poultsides, Scott I. Reznik, Robert E. Roses, Vivian E. Strong, Stacey Su, Hanlin L. Wang, Georgia L. Wiesner, Christopher G. Willett, Danny Yakoub, Harry H. Yoon, Nicole R. McMillian, Lenora A. Pluchino - Journal of the National Comprehensive Cancer Network 2023 cited by 520

  4. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2021 cited by 1,006

  5. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Shafique, Saiama N. Waqar, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2021 cited by 461

  6. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George A. Poultsides, Robert E. Roses, Vivian E. Strong, Georgia L. Wiesner, Christopher G. Willett, Cameron D. Wright, Nicole R. McMillian, Lenora A. Pluchino - Journal of the National Comprehensive Cancer Network 2019 cited by 1,097

  7. Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2017 cited by 1,325

  8. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Stevenson, Scott J. Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, OCN, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2019 cited by 1,005

  9. Esophageal and Esophagogastric Junction Cancers, Version 1.2015

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas K. Varghese, M. Kay Washington, Christopher G. Willett, Cameron D. Wright, Debra Zelman, Nicole R. McMillian, Hema Sundar - Journal of the National Comprehensive Cancer Network 2015 cited by 653

  10. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Walter J. Scott, Vivian E. Strong, M. Kay Washington, Benny Weksler, Christopher G. Willett, Cameron D. Wright, Debra Zelman, Nicole R. McMillian, Hema Sundar - Journal of the National Comprehensive Cancer Network 2016 cited by 957

  11. Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer

    Authors: , , , , , , , , , , - Annals of Surgery 2021 cited by 101

  12. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Stevenson, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2016 cited by 738

  13. The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer

    Authors: , , , , , , , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2023 cited by 76

  14. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database

    Authors: , , , , , , , - Journal of Surgical Research 2015 cited by 205

  15. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 358

  16. Gastric Cancer, Version 2.2013

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hema Sundar - Journal of the National Comprehensive Cancer Network 2013 cited by 515

  17. Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non–small cell lung cancer

    Authors: , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2021 cited by 111

  18. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database

    Authors: , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2010 cited by 798

  19. Esophageal and Esophagogastric Junction Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2011 cited by 335

  20. A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma

    Authors: , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2019 cited by 85

  21. Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , - International Journal of Surgery 2023 cited by 65

  22. Non–Small Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric Rohren, George R. Simon, Scott J. Swanson, Douglas E. Wood, Stephen C. Yang - Journal of the National Comprehensive Cancer Network 2010 cited by 735

  23. Non–Small Cell Lung Cancer, Version 6.2015

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven E. Schild, Theresa A. Shapiro, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2015 cited by 487

  24. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle

    Authors: , , , , , , , , , - BMC Medical Genomics 2011 cited by 139